Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.35 |
| ▸ | CDK5R1 | Q15078 | 3/20 | 0.35 |
| ▸ | NSD2 | O96028 | 2/20 | 0.35 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22992106 | 0.88 | FAAH (0.38) | TRPV1ALDH1A1KMT2A | |
| SCHEMBL21344667 | 0.85 | SMN1; SMN2 (0.42) | SMN1; SMN2HIF1A | |
| SCHEMBL21343728 | 0.84 | CYP3A4 (0.31) | NSD2KMT2A | |
| SCHEMBL21344695 | 0.83 | TRPV1 (0.36) | TRPV1NSD2 | |
| SCHEMBL22942059 | 0.83 | RAB9A (0.35) | RAB9AMAPTSMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL22992138 | 0.82 | CHRM2 (0.40) | SMN1; SMN2ALDH1A1NSD2KMT2A | |
| SCHEMBL22992095 | 0.82 | PIK3CA (0.34) | HIF1A | |
| SCHEMBL21344636 | 0.81 | L3MBTL1 (0.44) | SMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL24324680 | 0.81 | NPC1 (0.35) | RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A | |
| SCHEMBL21344248 | 0.80 | HIF1A (0.32) | HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043599-B2 | Herbicidal compounds | SYNGENTA PARTICIPATIONS AG (CH) | 2024-07-23 | — | — | US | disclosed |
| EP-3762378-B1 | HERBICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2022-05-18 | — | — | EP | disclosed |
| US-20210047274-A1 | HERBICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047274-A1 | HERBICIDAL COMPOUNDS | DDT, CBR3, GLRX3 | TRPV1 2779/4885RAB9A 1979/4885MAPT 3999/4885 |
| US-12043599-B2 | Herbicidal compounds | DDT, CBR3, GLRX3 | TRPV1 2779/4885RAB9A 1979/4885MAPT 3999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.